Advisory Board January 31, 2023
While weight-loss drugs like Wegovy are being hailed as “weight loss miracles,” many people cannot afford to stay on the medication long term—and they often experience “devastating” rebound weight gain when they stop taking it, Allison Aubrey writes for NPR’s “Shots.”
Barriers to ‘weight loss miracles’
Weight-loss drugs like Wegovy and Ozempic have been regarded by many as “weight loss miracles,” Aubrey writes. Currently, millions of Americans are eligible take these drugs.
While Ozempic is approved for diabetes, Wegovy is approved for individuals with obesity who have other weight-related conditions that increase their risk of heart disease.
According to FDA, people are eligible to take Wegovy if their BMI is 27 or higher and they have at least one “weight-related...
Today's Sponsors
Today's Sponsor